Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prospective evaluation of biologic treatment response in severe asthma
NL-OMON24843Recruiting
- Sponsor
- Frisius MC
- Start
- Jan 2016
- Countries
- 1
01
Overview
Open-label, single-arm trial in severe asthma, sponsored by Frisius MC. Primary endpoint: Patient characteristics and biomarkers as predictors of response. Started Jan 2016; status: recruiting.
02
Conditions
severe asthma
Beyond the preview
Go deeper on NL-OMON24843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON24843.